Browsing: Biotechnology

SILVER SPRING, Md., Dec. 15, 2023 /PRNewswire/ — Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of…

– PADCEV plus pembrolizumab approved based on groundbreaking EV-302 trial – – Confirmatory trial found PADCEV plus pembrolizumab nearly doubled…

Manufacturing Growth Expected in 2024; Revenue to Increase 5.6%; Capital Expenditures to Increase 11.9%; Capacity Utilization Currently at 83%; Services…

Company thanks Sanjeev Narula for his role in the successful execution of Viatris’ Phase 1 strategy; Narula will support a…

Board of Directors Elects Melina Higgins New ChairPITTSBURGH, Dec. 15, 2023 /PRNewswire/ — Viatris Inc. (NASDAQ: VTRS), a global healthcare…

LEHI, Utah, Dec. 15, 2023 /PRNewswire/ — Halia Therapeutics, a clinical-stage biopharmaceutical company pioneering a novel class of small molecule…

Sponsorship of the Golf Event Continues Following Horizon Acquisition Golfers Shane Lowry, Pádraig Harrington, Séamus Power and Brendan Lawlor Will…

LUND, Sweden, Dec. 13, 2023 /PRNewswire/ — Hansa Biopharma today announced that the Nomination Committee has been formed in accordance…

Analysis from MonumenTAL-1 study showed patients with relapsed or refractory multiple myeloma treated with TALVEY™ were subsequently treated effectively with several…